The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.

Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...

A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.

Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...

Herpes simplex virus is a master of bad timing—reappearing briefly, often unnoticed, and just long enough to keep the immune system on its toes. In its genital form, herpes simplex virus type 2 (HSV-2 ...

Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...

Forbes contributors publish independent expert analyses and insights. An experienced weaver of health, technology, ethics and spirituality. Every single second around the world, someone is infected ...

HealthDay News — A once-promising investigational vaccine against herpes viruses showed only 20% efficacy against herpes genital disease in a large clinical trial designed to mimic the general ...

The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and 49 live with a genital herpes infection. That's equivalent to one in every ...